Joseph A. Mollica

Who is Joseph A. Mollica?

Dr. Mollica is the Chairman of Pharmacopeia. From 1994-2004 Dr.

Mollica served as Chairman, President and Chief Executive Officer of

Pharmacopeia, Inc. which consisted of the Pharmacopeia Drug Discovery

division and Accelrys, the software division, through which the company

provided modeling and simulation software, cheminformatics and

bioinformatics to the pharmaceutical and chemical industries. In 2004,

Pharmacopeia spun out Accelrys to its shareholders. From 1987 to 1993,

Dr. Mollica was employed by the DuPont Company and then by the DuPont

Merck Pharmaceutical Company where, from 1991 to 1993, he served as

President and Chief Executive Officer and previously as Vice President,

Medical Products for DuPont. At Ciba-Geigy, where he was employed from

1966 to 1986, he served in a variety of positions of increasing

responsibility, rising to Senior Vice President of Ciba-Geigy’s

Pharmaceutical Division.

Dr. Mollica is currently also on the Boards of Linguagen Corp., and

Neurocrine Biosciences. He received his BS from the University of Rhode

Island and his MS and PhD from the University of Wisconsin and ScD,

h.c. from the University of Rhode Island.